Table 2.
Prevalence of left ventricular hypertrophy (LVH) and elevated biomarkers (High-sensitivity cardiac troponin-T (hs-cTnT) ≥ 6 and N-terminal pro-brain natriuretic peptide (NT-proBNP) ≥ 100), among men and women in the pooled cohort stratified by race/ethnicity.
| Men | Women | |||||
|---|---|---|---|---|---|---|
| Black (N = 2007) |
White (N = 4876) |
P value | Black (N = 2990) |
White (N = 5837) |
P value | |
|
LVH(+) Biomarker (+) (Malignant LVH) n (%) |
247 (12.3) | 200 (4.1) | <0.0001 | 189 (6.3) | 121 (2.1) | <0.0001 |
|
LVH (+) Biomarker (−) n (%) |
185 (9.2) | 140 (2.9) | <0.0001 | 249 (8.3) | 90 (1.5) | <0.0001 |
|
LVH (−) n (%) |
1575 (78.5) | 4536 (93) | <0.0001 | 2552 (85.4) | 5626 (96.4) | <0.0001 |